Corporate
  • SATT Aquitaine Science Transfert

    Created in 2012
  • Social networks

    4,043 4,043
  • Global tags

  • Location

    A31, 351 Cr de la Libération, 33400 Talence, France

    Talence

    France

  • SIREN

    753027663
  • Engaged entities

    135
    33 76
  • Added in Motherbase

    12 Jan 2024, 4:07 p.m.
Description
  • Value proposition

    Valorisons les inventions qui façonnent le monde de demain !

    Aquitaine Science Transfert is the Nouvelle Aquitaine TTO (Technology Transfer Office). Our mission is to generate economic and social value out of public research, whether it deals with startups creation or patent licensing.

    Thanks to all researchers in Aquitaine region, we cover all fields of science : health and medical, aeronautics, space and defence, green techs, energy, utilities, engineers science, social and human sciences, etc.

    We represent our shareholders : University of Bordeaux, Bordeaux INP (publicengineers school), the National Center for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM), Pau and Pays of Adour University (UPPA), ESTIA, Bergonié Institute, Bordeaux Universitary Hospital Center (CHU Bordeaux), Bordeaux IEP, Bordeaux Montaigne University and Bordeaux Sciences Agro (BSA).

    Since our inception, we have helped incorporate 13 startups and put 7 products & services on the market, signed 37 license agreements with private companies, patented 243 technologies and softwares, and signed 2 120 research contracts on behalf of our shareholder establishments. On the whole, we have invested M€ 10.4 in the maturation of technologies and M€ 2.8 in the IP portfolio of our shareholder establishments.

    technology transfer, innovation, research, technology licensing, innovation licensing, science transfer, and research valuation

  • Original language

    Valorisons les inventions qui façonnent le monde de demain !

    Aquitaine Science Transfert is the Nouvelle Aquitaine TTO (Technology Transfer Office). Our mission is to generate economic and social value out of public research, whether it deals with startups creation or patent licensing.

    Thanks to all researchers in Aquitaine region, we cover all fields of science : health and medical, aeronautics, space and defence, green techs, energy, utilities, engineers science, social and human sciences, etc.

    We represent our shareholders : University of Bordeaux, Bordeaux INP (publicengineers school), the National Center for Scientific Research (CNRS), the French National Institute of Health and Medical Research (INSERM), Pau and Pays of Adour University (UPPA), ESTIA, Bergonié Institute, Bordeaux Universitary Hospital Center (CHU Bordeaux), Bordeaux IEP, Bordeaux Montaigne University and Bordeaux Sciences Agro (BSA).

    Since our inception, we have helped incorporate 13 startups and put 7 products & services on the market, signed 37 license agreements with private companies, patented 243 technologies and softwares, and signed 2 120 research contracts on behalf of our shareholder establishments. On the whole, we have invested M€ 10.4 in the maturation of technologies and M€ 2.8 in the IP portfolio of our shareholder establishments.

Entity interactions BETA
Entity TypeTweets Articles
PhDOOC PhDOOC
edtech
Other

14 Mar 2024


Confédération des Jeunes Chercheurs (CJC) Confédération des Jeunes Chercheurs (CJC)
edtech, Think Tanks
Other

14 Mar 2024


Corlieve Therapeutics Corlieve Therapeutics
biotech, deeptech
Other

6 Feb 2024


Bordeaux Neurocampus Bordeaux Neurocampus
Think Tanks, deeptech
Other

29 Feb 2024


Inserm Transfert Inserm Transfert
Biotechnology Research
Other

10 Apr 2024


REGENXBIO Inc. REGENXBIO Inc.
biotech, deeptech
Other

6 Feb 2024


Nowatt Lighting Nowatt Lighting
greentech, cleantech, manufacturing, Renewable Energy Semiconductor Manufacturing
Other

6 Dec 2022


IRDI Capital Investissement IRDI Capital Investissement
Venture Capital and Private Equity Principals
Other

1 Dec 2022


SKALEPARK SKALEPARK
Other

1 Dec 2022


Newfund Newfund
Venture Capital and Private Equity Principals
Other

6 Dec 2023


Radars
Loading...